U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Paranasal Sinus Squamous Cell Carcinoma

MedGen UID:
1649419
•Concept ID:
C4724995
•
Neoplastic Process

Definition

The reemergence of paranasal sinus squamous cell carcinoma after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Paranasal Sinus Squamous Cell Carcinoma

Professional guidelines

PubMed

Outcomes of multimodal management for sinonasal squamous cell carcinoma.
Paré A, Blanchard P, Rosellini S, Aupérin A, Gorphe P, Casiraghi O, Temam S, Bidault F, Page P, Kolb F, Janot F, Moya Plana A
J Craniomaxillofac Surg 2017 Aug;45(8):1124-1132. Epub 2017 May 12 doi: 10.1016/j.jcms.2017.05.006. PMID: 28601297
Sinonasal inverted papilloma: From diagnosis to treatment.
Lisan Q, Laccourreye O, Bonfils P
Eur Ann Otorhinolaryngol Head Neck Dis 2016 Nov;133(5):337-341. Epub 2016 Apr 1 doi: 10.1016/j.anorl.2016.03.006. PMID: 27053431
Management of the neck in maxillary sinus carcinomas.
Dooley L, Shah J
Curr Opin Otolaryngol Head Neck Surg 2015 Apr;23(2):107-14. doi: 10.1097/MOO.0000000000000138. PMID: 25692625Free PMC Article

Recent clinical studies

Etiology

Long-term outcomes in sinonasal squamous cell carcinoma arising from inverted papilloma: Systematic review.
Birkenbeuel JL, Pang JC, Lee A, Nguyen ES, Risbud A, Goshtasbi K, Abiri A, Lehrich BM, Tong CCL, Adappa ND, Palmer JN, Kuan EC
Head Neck 2022 Apr;44(4):1014-1029. Epub 2022 Feb 9 doi: 10.1002/hed.26995. PMID: 35141984
Serum, plasma and saliva biomarkers for head and neck cancer.
Arantes LMRB, De Carvalho AC, Melendez ME, Lopes Carvalho A
Expert Rev Mol Diagn 2018 Jan;18(1):85-112. Epub 2017 Nov 20 doi: 10.1080/14737159.2017.1404906. PMID: 29134827
Posttreatment surveillance for sinonasal malignancy.
Workman AD, Palmer JN, Adappa ND
Curr Opin Otolaryngol Head Neck Surg 2017 Feb;25(1):86-92. doi: 10.1097/MOO.0000000000000330. PMID: 27846019
Sinonasal inverted papilloma: From diagnosis to treatment.
Lisan Q, Laccourreye O, Bonfils P
Eur Ann Otorhinolaryngol Head Neck Dis 2016 Nov;133(5):337-341. Epub 2016 Apr 1 doi: 10.1016/j.anorl.2016.03.006. PMID: 27053431
Paranasal sinus cancer.
Jégoux F, Métreau A, Louvel G, Bedfert C
Eur Ann Otorhinolaryngol Head Neck Dis 2013 Dec;130(6):327-35. Epub 2013 Mar 21 doi: 10.1016/j.anorl.2012.07.007. PMID: 23523040

Diagnosis

Head and neck cancer: Current challenges and future perspectives.
Bhat GR, Hyole RG, Li J
Adv Cancer Res 2021;152:67-102. Epub 2021 Jun 16 doi: 10.1016/bs.acr.2021.05.002. PMID: 34353444
Serum, plasma and saliva biomarkers for head and neck cancer.
Arantes LMRB, De Carvalho AC, Melendez ME, Lopes Carvalho A
Expert Rev Mol Diagn 2018 Jan;18(1):85-112. Epub 2017 Nov 20 doi: 10.1080/14737159.2017.1404906. PMID: 29134827
Posttreatment surveillance for sinonasal malignancy.
Workman AD, Palmer JN, Adappa ND
Curr Opin Otolaryngol Head Neck Surg 2017 Feb;25(1):86-92. doi: 10.1097/MOO.0000000000000330. PMID: 27846019
Sinonasal inverted papilloma: From diagnosis to treatment.
Lisan Q, Laccourreye O, Bonfils P
Eur Ann Otorhinolaryngol Head Neck Dis 2016 Nov;133(5):337-341. Epub 2016 Apr 1 doi: 10.1016/j.anorl.2016.03.006. PMID: 27053431
Paranasal sinus cancer.
Jégoux F, Métreau A, Louvel G, Bedfert C
Eur Ann Otorhinolaryngol Head Neck Dis 2013 Dec;130(6):327-35. Epub 2013 Mar 21 doi: 10.1016/j.anorl.2012.07.007. PMID: 23523040

Therapy

Sinonasal cancers treatments: state of the art.
Ferrari M, Orlandi E, Bossi P
Curr Opin Oncol 2021 May 1;33(3):196-205. doi: 10.1097/CCO.0000000000000726. PMID: 33756515Free PMC Article
Cetuximab and paclitaxel combination therapy for recurrent basaloid squamous cell carcinoma in the ethmoid sinus.
Koyama S, Fujiwara K, Morisaki T, Fujii T, Nakamura Y, Fukuhara T, Takeuchi H
Auris Nasus Larynx 2021 Dec;48(6):1189-1192. Epub 2020 Jul 16 doi: 10.1016/j.anl.2020.07.002. PMID: 32684403
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC).
Cohen EEW, Bell RB, Bifulco CB, Burtness B, Gillison ML, Harrington KJ, Le QT, Lee NY, Leidner R, Lewis RL, Licitra L, Mehanna H, Mell LK, Raben A, Sikora AG, Uppaluri R, Whitworth F, Zandberg DP, Ferris RL
J Immunother Cancer 2019 Jul 15;7(1):184. doi: 10.1186/s40425-019-0662-5. PMID: 31307547Free PMC Article
Paranasal sinus cancer.
Jégoux F, Métreau A, Louvel G, Bedfert C
Eur Ann Otorhinolaryngol Head Neck Dis 2013 Dec;130(6):327-35. Epub 2013 Mar 21 doi: 10.1016/j.anorl.2012.07.007. PMID: 23523040
Induction chemotherapy for advanced squamous cell carcinoma of the paranasal sinuses.
Hanna EY, Cardenas AD, DeMonte F, Roberts D, Kupferman M, Weber R, Rosenthal D, Kies M
Arch Otolaryngol Head Neck Surg 2011 Jan;137(1):78-81. doi: 10.1001/archoto.2010.231. PMID: 21242552

Prognosis

Head and neck cancer: Current challenges and future perspectives.
Bhat GR, Hyole RG, Li J
Adv Cancer Res 2021;152:67-102. Epub 2021 Jun 16 doi: 10.1016/bs.acr.2021.05.002. PMID: 34353444
DEK-AFF2 Carcinoma of the Sinonasal Region and Skull Base: Detailed Clinicopathologic Characterization of a Distinctive Entity.
Rooper LM, Agaimy A, Dickson BC, Dueber JC, Eberhart CG, Gagan J, Hartmann A, Khararjian A, London NR, MacMillan CM, Palsgrove DN, Nix JS, Sandison A, Stoehr R, Truong T, Weinreb I, Bishop JA
Am J Surg Pathol 2021 Dec 1;45(12):1682-1693. doi: 10.1097/PAS.0000000000001741. PMID: 34049316
Sinonasal cancers treatments: state of the art.
Ferrari M, Orlandi E, Bossi P
Curr Opin Oncol 2021 May 1;33(3):196-205. doi: 10.1097/CCO.0000000000000726. PMID: 33756515Free PMC Article
Posttreatment surveillance for sinonasal malignancy.
Workman AD, Palmer JN, Adappa ND
Curr Opin Otolaryngol Head Neck Surg 2017 Feb;25(1):86-92. doi: 10.1097/MOO.0000000000000330. PMID: 27846019
Paranasal sinus cancer.
Jégoux F, Métreau A, Louvel G, Bedfert C
Eur Ann Otorhinolaryngol Head Neck Dis 2013 Dec;130(6):327-35. Epub 2013 Mar 21 doi: 10.1016/j.anorl.2012.07.007. PMID: 23523040

Clinical prediction guides

Head and neck cancer: Current challenges and future perspectives.
Bhat GR, Hyole RG, Li J
Adv Cancer Res 2021;152:67-102. Epub 2021 Jun 16 doi: 10.1016/bs.acr.2021.05.002. PMID: 34353444
Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses.
Abdelmeguid AS, Teeramatwanich W, Roberts DB, Amit M, Ferraroto R, Glisson BS, Kupferman ME, Su SY, Phan J, Garden AS, Raza SM, DeMonte F, Hanna EY
Cancer 2021 Jun 1;127(11):1788-1795. Epub 2021 Feb 10 doi: 10.1002/cncr.33452. PMID: 33567468
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC).
Cohen EEW, Bell RB, Bifulco CB, Burtness B, Gillison ML, Harrington KJ, Le QT, Lee NY, Leidner R, Lewis RL, Licitra L, Mehanna H, Mell LK, Raben A, Sikora AG, Uppaluri R, Whitworth F, Zandberg DP, Ferris RL
J Immunother Cancer 2019 Jul 15;7(1):184. doi: 10.1186/s40425-019-0662-5. PMID: 31307547Free PMC Article
Serum, plasma and saliva biomarkers for head and neck cancer.
Arantes LMRB, De Carvalho AC, Melendez ME, Lopes Carvalho A
Expert Rev Mol Diagn 2018 Jan;18(1):85-112. Epub 2017 Nov 20 doi: 10.1080/14737159.2017.1404906. PMID: 29134827
Posttreatment surveillance for sinonasal malignancy.
Workman AD, Palmer JN, Adappa ND
Curr Opin Otolaryngol Head Neck Surg 2017 Feb;25(1):86-92. doi: 10.1097/MOO.0000000000000330. PMID: 27846019

Recent systematic reviews

Recurrence rates of de-novo versus inverted papilloma-transformed sinonasal squamous cell carcinoma: a meta-analysis.
Birkenbeuel JL, Goshtasbi K, Adappa ND, Palmer JN, Tong CCL, Kuan EC
Rhinology 2022 Dec 1;60(6):402-410. doi: 10.4193/Rhin22.187. PMID: 36150160
Long-term outcomes in sinonasal squamous cell carcinoma arising from inverted papilloma: Systematic review.
Birkenbeuel JL, Pang JC, Lee A, Nguyen ES, Risbud A, Goshtasbi K, Abiri A, Lehrich BM, Tong CCL, Adappa ND, Palmer JN, Kuan EC
Head Neck 2022 Apr;44(4):1014-1029. Epub 2022 Feb 9 doi: 10.1002/hed.26995. PMID: 35141984
Prognostic Factors and Outcomes of De Novo Sinonasal Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.
Nguyen ES, Risbud A, Birkenbeuel JL, Murphy LS, Goshtasbi K, Pang JC, Abiri A, Lehrich BM, Haidar YM, Tjoa T, Kuan EC
Otolaryngol Head Neck Surg 2022 Mar;166(3):434-443. Epub 2021 Jul 13 doi: 10.1177/01945998211021023. PMID: 34253092
Clinical evidence based review and systematic scientific review in the identification of malignant transformation of inverted papilloma.
Long C, Jabarin B, Harvey A, Ham J, Javer A, Janjua A, Thamboo A
J Otolaryngol Head Neck Surg 2020 Apr 30;49(1):25. doi: 10.1186/s40463-020-00420-x. PMID: 32354352Free PMC Article

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...